GELS

2025 Non-GAAP Net Income Totaled $162,000 or $0.02 Per ShareRecord Results Driven by Fifth Sequential Quarter of Record-Setting Revenues, with the Momentum Setting Stage for Another Year of Double-Digit GrowthLAS VEGAS, NV / ACCESS Newswire / April 8, 2026 / Healthy Extracts Inc. (OTCQB:HYEX), a leader in nutraceutical innovations and precision dose gummy manufacturing, reported audited results for the year ended December 31, 2025. All comparisons are to the same year-ago period unless otherwise noted.2025 Financial Highlights2025 net revenue increased 45% to a record $4.5 million, with the increase due to the merger with Gummy USA™, continued technological innovation, product line and distr

Strong Annual Results Driven by Record-Setting Revenues for Fifth Quarter in a Row, Setting Stage for Another Record Year in 2026LAS VEGAS, NV / ACCESS Newswire / April 2, 2026 / Healthy Extracts Inc. (OTCQB:HYEX), a leader in nutraceutical innovations and precision dose gummy manufacturing, reported preliminary unaudited results for year ended December 31, 2025. All comparisons are to the same year-ago period unless otherwise noted.2025 Financial Highlights2025 net revenue is expected to increase 45% to a record $4.5 million, with the increase due to the merger with Gummy USA, continued technological innovation, product line and distribution channel expansion, and strengthening direct-to-co

6-K - Gelteq Ltd (0001920092) (Filer)

3 - Gelteq Ltd (0001920092) (Issuer)

3 - Gelteq Ltd (0001920092) (Issuer)

3 - Gelteq Ltd (0001920092) (Issuer)

3 - Gelteq Ltd (0001920092) (Issuer)

MELBOURNE, Australia and LAS VEGAS, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Gelteq Limited ("Gelteq") and Healthy Extracts™ Inc. ("Healthy Extracts") today announced the signing of a Memorandum of Understanding ("MoU") formalising a strategic partnership designed to accelerate the commercial rollout of next-generation gel-based nutraceutical products. The collaboration builds on Healthy Extracts' prior purchases of Gelteq-formulated products and marks the first phase of a long-term plan to bring Gelteq's proprietary gel delivery technology to large-scale US manufacturing and global distribution. Under the MoU, Healthy Extracts will leverage its established US-based nutritional manufacturing cap

MELBOURNE, Australia, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Gelteq Limited ("Gelteq" or the "Company"), a clinical and science-based developer of advanced gel-based oral delivery systems, today announced positive results from a recently completed preclinical study which evaluated medicinal cannabinoids delivery through the Company's proprietary oral gel platform. The findings demonstrate that Gelteq's platform significantly enhances the absorption and bioavailability of cannabidiol ("CBD") compared to an existing FDA approved oil-based product. The preliminary results reinforces our platform's potential to change how medicinal cannabis is delivered and experienced by patients. Despite having

MELBOURNE, Australia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited ("Gelteq" or the "Company"), a clinical and science-based company specialising in gel-based oral delivery solutions, today announced a new partnership with the Hong Kong Flag Football Program. The partnership will integrate Gelteq's advanced hydration and sports performance formulations into the training and competition programs of the region's men's, women's, and youth national teams. The initiative underscores the increasing interest in high-performance programs throughout the region and builds on the recently announced China-focused sales agreement with Shenzhen Mana Health Management Co. Ltd., which includes minimu

6-K - Gelteq Ltd (0001920092) (Filer)

MELBOURNE, Australia, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited ("Gelteq" or the "Company"), a clinical and science based innovator in gel based oral delivery technologies, today announced that it has entered into a three year sales agreement with Shenzhen Mana Health Management Co. Ltd. ("Mana") under which Mana will distribute consumer nutritional products within China using Gelteq's proprietary gel formulation. The agreement represents a significant step forward in expanding Gelteq's nutritional product portfolio in China. Mana is a well-established distributor of healthcare and wellness products in China with a strong digital presence and a network of offline retail sales chann

MELBOURNE, Australia, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited ("Gelteq" or the "Company"), a clinical and science-based developer of advanced gel-based oral delivery systems, today announced preclinical findings demonstrating the effectiveness, flexibility, and safety profile of its proprietary gel platform. The results address a major challenge in pharmaceutical development and demonstrate that Gelteq's technology can enhance the oral delivery of oil-soluble and poorly soluble drugs. Across two complementary preclinical studies, the results showed a more rapid absorption of an oil soluble compound in Gelteq's gel base compared to an existing FDA approved reference product, with

MELBOURNE, Australia, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ:GELS) ("Gelteq") today announced that Nathan Givoni, its Chief Executive Officer, will present at the Q4 Investor Summit Virtual on December 9, 2025, where he will share updates on Gelteq's growth strategy, market positioning, and upcoming catalysts. The Investor Summit is an exclusive virtual event connecting investors with disruptive small and microcap companies. This quarter's event highlights MicroCap companies with compelling value propositions and near-term growth drivers, offering investors a focused platform for discovery. Mr. Givoni will be presenting on December 9 at 4:00 PM ET, together with hosting

MELBOURNE, Australia, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited ("Gelteq" or the "Company"), a clinical and science-based company specialising in gel-based oral delivery solutions, today announced positive preclinical results showing its proprietary gel formulation achieved substantially higher bioavailability than a leading on-market reference antihistamine product. In a comparative pharmacokinetic study, Gelteq's formulation demonstrated a 38–45% increase in systemic exposure and absorption (AUC) and markedly higher peak concentrations (Cmax), while maintaining a comparable time to peak plasma concentration (Tmax). The results of the study show Gelteq's gel-based delivery technol

LAS VEGAS, NV / ACCESS Newswire / November 14, 2025 / Healthy Extracts Inc. (OTCQB:HYEX), a leader in plant-based nutraceutical innovations, reported results for the third quarter and nine months ended September 30, 2025. All comparisons are to the same year-ago period unless otherwise noted.Q3 and 9M 2025 Financial HighlightsIn Q3 2025, net revenue increased 23% to a record for a third quarter totaling $918,000. On a first nine-month basis, net revenue increased 20% to a record $2.8 million. The growth was driven by technological innovation combined with strong direct-to-consumer and retail sales.Gross profit in the third quarter decreased 26% to $447,000 or 48.7% of net revenue. On a nine-

LAS VEGAS, NV / ACCESS Newswire / November 11, 2025 / Healthy Extracts Inc. (OTCQB:HYEX), a leader in science-based nutraceuticals and oral delivery technology for transformational health and longevity, has been invited to present at the annual fall Trickle Research Microcap Conference being held at the Topgolf Centennial in Centennial, Colorado on November 13, 2025.On the day of the event, a live stream of the conference can be viewed here. Healthy Extracts is scheduled to present at 3:06 p.m. Mountain time (5:06 p.m. Eastern time).Hosted by Trickle Research, the conference connects buy-side investors with select public companies within the microcap equities market. The exclusive, invitatio

NT 20-F - Gelteq Ltd (0001920092) (Filer)

MELBOURNE, Australia, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (("Gelteq" or the "Company, NASDAQ:GELS), a clinical and science-based developer of gel-based oral delivery solutions, welcomes the recently announced product launches of Healthy Extracts, Inc. (("Healthy Extracts, OTCQB:HYEX), whose products apply Gelteq's proprietary gel technology, into the U.S. nutraceutical market. The Healthy Extracts products are the first to reach Gelteq's U.S. warehousing facility using Gelteq's delivery platform, an important milestone that marks Gelteq's transition from R&D to active commercialization in the U.S. This development highlights both the growth potential of Gelteq's technology

Hydrate EZ™ delivers rapid hydration and essential electrolytes for staying refreshed, sharp and in control.Mynus Sugar™ is clinically formulated to support healthy carbohydrate metabolism.Both products feature exclusive oral delivery technology in a flavorful, super-convenient, 2-oz. gel pack format-no water or mixing required.Proprietary gel manufacturing process complements company's new exclusive SureDose™ gummy manufacturing and functional drinking straw technologies. LAS VEGAS, NV / ACCESS Newswire / September 4, 2025 / Healthy Extracts™ Inc. (OTCQB:HYEX), a platform for acquiring, developing, manufacturing and marketing science-based nutraceuticals for brain, heart, and metabolic heal

EFFECT - Gelteq Ltd (0001920092) (Filer)

424B3 - Gelteq Ltd (0001920092) (Filer)

Net Revenue Outlook for 2025 Increased from $4.2 Million+ to $6.3 Million+, Representing Growth of 102%+, Based on Recent Transformative Merger with Gummy USA LAS VEGAS, NV / ACCESS Newswire / August 13, 2025 / Healthy Extracts Inc. (OTCQB:HYEX), a leader in plant-based nutraceutical innovations, reported results for its second quarter and six months ended June 30, 2025. All comparisons are to the same year-ago period unless otherwise noted.Q2 Financial HighlightsNet revenue totaled a record $969,000, increasing 4% from the previous quarter and up 7% compared to the same year-ago quarter. On a first six-month basis, net revenue increased 19% to a record $1.9 million.Second quarter net revenu

F-1/A - Gelteq Ltd (0001920092) (Filer)

Q2 2025 adjusted EBIDTA at nearly $100,000, demonstrating strong leverage in the company's marketing and distribution channel platform.Subscription-based recurring revenue continues to drive strong positive cash flow with more than 107% increase from Amazon "Subscribe & Save" customers and 88% increase in DTC subscription customers.Continued market and product line expansion keeping performance on track for another record second half and full year; maintaining guidance of 34% net revenue growth in 2025. LAS VEGAS, NEVADA / ACCESS Newswire / July 22, 2025 / Healthy Extracts Inc. (OTCQB:HYEX), a leader in research-based nutraceuticals for transformational health and longevity, reported prelimi